We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Having survived the Utah Senate, a bill holding reprocessors of "single-use"
medical devices completely liable for the recycled products' safety could come
to a final House vote within a week.
The University of Texas M.D. Anderson Cancer Center
has granted an exclusive license to Quest Diagnostics for the use of five proprietary
blood testing methods that have the potential to eliminate the need for painful
and expensive bone marrow and other tissue extractions.
B. Braun announced the availability of the LidoSite Topical System, a method
to help reduce needlestick pain associated with procedures such as intravenous
cannulation, venipuncture or laser ablation of superficial skin lesions for
patients ages 5 and up.
Align Technology, the inventor of Invisalign -- a proprietary method of straightening
teeth without wires and brackets has announced the acquisition of General Orthodontic
(GO) as part of the company's ongoing commitment to providing clinical support
for Invisalign doctors.
The FDA warned consumers not to use unapproved home-use diagnostic test kits
that have been marketed nationwide via the internet by Globus Media, Montreal,
Canada.
The FDA has released highlights of its fiscal 2006 budget request to Congress
totaling $1.9 billion, including $1.5 billion in budget authority and $382 million
in congressionally authorized industry user fees -- 50 percent higher than the
appropriations in fiscal 2001 and a 4.5 percent increase over the fiscal 2005
level.
As part of its steadfast effort to control the spread of tuberculosis (TB),
the San Francisco Health Department became the first county health department
in the U.S. to use QuantiFERON-TB GOLD, an indirect test for TB infection, according
to Cellestis.
BioE, a biotechnology company developing antibody-based technology platforms
for therapeutic and diagnostic applications, has received $8.3 million in its
latest round of private financing.